123 related articles for article (PubMed ID: 9894725)
21. Relapse of Graves' disease after successful allogeneic bone marrow transplantation.
Hsiao LT; Liu JH; Yen CC; Wang WS; Fan FS; Chiou TJ; Chen PM
Bone Marrow Transplant; 2001 Dec; 28(12):1151-3. PubMed ID: 11803358
[TBL] [Abstract][Full Text] [Related]
22. [Skin manifestations of graft-versus-host reaction following bone marrow transplantation].
Itin PH; Lautenschlager S; Orth B; Rufli T; Gratwohl A
Schweiz Med Wochenschr; 1996 Mar; 126(9):339-47. PubMed ID: 8701251
[TBL] [Abstract][Full Text] [Related]
23. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
Du B; Li DP; Xu KL; Pan XY
Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128
[TBL] [Abstract][Full Text] [Related]
24. Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease.
Toze CL; Galal A; Barnett MJ; Shepherd JD; Conneally EA; Hogge DE; Nantel SH; Nevill TJ; Sutherland HJ; Connors JM; Voss NJ; Kiss TL; Messner HA; Lavoie JC; Forrest DL; Song KW; Smith CA; Lipton J
Bone Marrow Transplant; 2005 Nov; 36(9):825-30. PubMed ID: 16151430
[TBL] [Abstract][Full Text] [Related]
25. Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease.
Anderson LD; Mori S; Mann S; Savary CA; Mullen CA
Cancer Res; 2000 Oct; 60(20):5797-802. PubMed ID: 11059776
[TBL] [Abstract][Full Text] [Related]
26. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
[TBL] [Abstract][Full Text] [Related]
27. Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.
Michallet M; Perrin MC; Belhabri A; Molina L; Nicolini F; Tigaud JD; Sotto JJ; Guyotat D; Fière D; Archimbaud E
Bone Marrow Transplant; 1999 Jan; 23(2):145-50. PubMed ID: 10197799
[TBL] [Abstract][Full Text] [Related]
28. Mixed chimera converted into full donor chimera with powerful graft-versus-leukemia effects but no graft-versus-host disease after non T cell-depleted HLA-mismatched peripheral blood stem cell transplantation.
Wu BY; Guo KY; Song CY; Yang ; Li D
Bone Marrow Transplant; 2000 Sep; 26(6):691-3. PubMed ID: 11035376
[TBL] [Abstract][Full Text] [Related]
29. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
[TBL] [Abstract][Full Text] [Related]
30. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
Li Y; Guo K; Chen Y; Song Z; Li J; Deng L
Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044
[TBL] [Abstract][Full Text] [Related]
31. Syngeneic graft-versus-host disease: a report of two cases and literature review.
Latif T; Pohlman B; Kalaycio M; Sobecks R; Hsi ED; Andresen S; Bolwell BJ
Bone Marrow Transplant; 2003 Sep; 32(5):535-9. PubMed ID: 12942102
[TBL] [Abstract][Full Text] [Related]
32. Atypical skin graft-vs.-host disease following bone marrow transplantation in an infant.
Kuskonmaz B; Güçer S; Boztepe G; Cetin M; Uckan D
Pediatr Transplant; 2007 Mar; 11(2):214-6. PubMed ID: 17300504
[TBL] [Abstract][Full Text] [Related]
33. Graft-versus-host reaction affecting lesional skin but not normal skin in a patient with piebaldism.
Chow RK; Stewart WD; Ho VC
Br J Dermatol; 1996 Jan; 134(1):134-7. PubMed ID: 8745900
[TBL] [Abstract][Full Text] [Related]
34. Chronic demyelinating polyneuropathy in graft-versus-host disease following allogeneic bone marrow transplantation.
Nagashima T; Sato F; Chuma T; Mano Y; Sasaki I; Mori M; Higa T; Masauji N; Kasai M; Orba Y; Shinohara T; Nagashima K
Neuropathology; 2002 Mar; 22(1):1-8. PubMed ID: 12030409
[TBL] [Abstract][Full Text] [Related]
35. Unrelated donor marrow transplantation for B-cell chronic lymphocytic leukemia after using myeloablative conditioning: results from the Center for International Blood and Marrow Transplant research.
Pavletic SZ; Khouri IF; Haagenson M; King RJ; Bierman PJ; Bishop MR; Carston M; Giralt S; Molina A; Copelan EA; Ringdén O; Roy V; Ballen K; Adkins DR; McCarthy P; Weisdorf D; Montserrat E; Anasetti C
J Clin Oncol; 2005 Aug; 23(24):5788-94. PubMed ID: 16043827
[TBL] [Abstract][Full Text] [Related]
36. Unusual infections following allogeneic bone marrow transplantation for chronic lymphocytic leukemia.
Zomas A; Mehta J; Powles R; Treleaven J; Iveson T; Singhal S; Jameson B; Paul B; Brincat S; Catovsky D
Bone Marrow Transplant; 1994 Nov; 14(5):799-803. PubMed ID: 7889013
[TBL] [Abstract][Full Text] [Related]
37. [Basedow disease occurring after allogeneic bone marrow transplantation for acute lymphoblastic leukemia].
Sasaki Y; Ito K
Rinsho Ketsueki; 2002 Sep; 43(9):833-5. PubMed ID: 12412287
[TBL] [Abstract][Full Text] [Related]
38. The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia.
Sánchez-García J; Serrano J; Gómez P; Martínez F; Martín C; Román-Gómez J; Rodríguez A; Herrera C; García JM; Alvarez MA; Torres A
Haematologica; 2006 Mar; 91(3):340-7. PubMed ID: 16531257
[TBL] [Abstract][Full Text] [Related]
39. Graft-vs-host disease.
Tran K; Kaplan J; Kamino H; Latkowski JA
Dermatol Online J; 2013 Dec; 19(12):20710. PubMed ID: 24365001
[TBL] [Abstract][Full Text] [Related]
40. Contrast media triggering cutaneous graft-versus-host disease.
Vavricka SR; Halter J; Furrer K; Wolfensberger U; Schanz U
Bone Marrow Transplant; 2002 Jun; 29(11):899-901. PubMed ID: 12080354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]